atricure.com (ATRC): Operatsion rentabellik

AtriCure Corp (ATRC) - korporativ logo

AtriCure, Inc. (ATRC) eksklyuziv patentlar va qat'iy FDA nazorati bilan himoyalangan, bu esa GURU.Markets grafigidagi operatsion marjaning o'zgarishi bilan tasdiqlanadi, u yerda 3.10 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Daromadlar o'sishi minimal invaziv tizimlarning joriy etilishi va huquqlarning huquqiy himoyasiga asoslangan. Yurak qurilmalariga bo'lgan yuqori talab iqtisodiy zarbalardan deyarli mustaqil bo'lgan barqaror pul oqimlarini kafolatlaydi.

ATRC - AtriCure Operatsion foyda koeffitsiyenti 04.07.2022 - 19.11.2026 oraligʻida

AtriCure (ATRC) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Fundamental baholash:ATRC, AtriCure Corp
atricure.com tayyor mahsulotlari

Operatsion marja moliyaviy xarajatlar va soliqlarni hisobga olguncha, umumiy tushumga nisbatan asosiy faoliyatdan olingan foyda ulushini belgilaydi. AtriCure, Inc. (ATRC) uchun ushbu ko'rsatkich robotlashtirilgan kriyoablatsiya tizimlari va avtomatlashtirilgan jarrohlik asboblarini tijoratlashtirish samaradorligini aks ettiradi. Asosiy biznes marjasini tahlil qilish orqali investor ishlab chiqarishni kengaytirish jarayonida kompaniyaning xarajatlarni nazorat qilish qobiliyatini baholaydi. Ko'rsatkichning tendentsiyasi modelning narxlar shoklariga chidamliligini namoyish etadi. Barqaror rentabellik darajasi emitent aktivlarining yuqori sifatini tasdiqlaydi.

AtriCure, Inc. raqobatchilari tahlili

ISRG (intuitive.com) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi DHR (Danaher Corp.)|Sotuvning operatsion marjasi BDX (Becton, Dickinson and Company)|Operatsion foyda koeffitsiyenti STE|Operatsion rentabellik West Pharma WST|Operatsion faoliyat rentabelligi Baxter (BAX)|MASI - Operatsion rentabellik|Operatsion faoliyat rentabelligi Stevanato Group Corp STVN|TFX: Operatsion marja|Sotuvning operatsion marjasi Merit Medical Systems|Operatsion rentabellik Envista Holdings Corp|Sotuvning operatsion marjasi ICU Medical Corp (ICUI)|Operatsion rentabellik DENTSPLY SIRONA Inc. (XRAY)|Sotuvning operatsion marjasi LeMaitre LMAT|Operatsion marja STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Sotuvning operatsion rentabelligi|ZimVie Inc - Operatsion marja|Sotuvning operatsion rentabelligi AngioDynamics|CERS (Cerus Corp) - Sotuvning operatsion marjasi|Alpha Teknova, Inc. - Operatsion foyda normasi|MGRM (Monogram Orthopedics Inc.) - Operatsion marja|STSS: Operatsion foyda normasi|Sotuvning operatsion marjasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja KRMD (korumedical.com)|Operatsion faoliyat rentabelligi Nyxoah, S.A. (NYXH)|MBOT - Operatsion rentabellik|PDEX (Pro-Dex, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|ZTEK (Zentek Ltd) - Sotuvning operatsion marjasi|ELUT - Operatsion faoliyat rentabelligi|MLSS (Milestone Scientific Corporation) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi NXGL (NEXGEL, Inc.)|Operatsion marja RVP|Sotuvning operatsion marjasi Harvard Bioscience HBIO|Operatsion marja FEMY (Femasys Corporation)|MHUA - Sotuvning operatsion marjasi|POAI - Operatsion rentabellik|Callan JMB (CJMB) - Sotuvning operatsion marjasi|ATRI: Operatsion marja|NURO - Operatsion faoliyat rentabelligi